Refalgin

CE medical device with mechanical action in the form of rapid gastric deglutible film tablets.
Alginate-based tablets derived from marine algae, indicated in the treatment of gastric reflux in order to reduce the symptoms related to it. It can be used during a continuous treatment with non-steroidal anti-inflammatory drugs such as primary gastropathy prophylaxis by Fans.

Ingredients
Alginic acid 365 mg; sodium alginate 300 mg; calcium carbonate; maltodextrin; sodium chloride; microcrystalline cellulose; silicon dioxide; symeticons; hydrogenated vegetable fat; magnesium stearate; water; filming: hydroxypropylcellulose.

Mode of use
To swallow 1 - 2 tablets after meals with a little water.
Wash your hands before and after using your medical device.
The duration of use depends on the evolution of symptoms, if necessary Refalgin tablets can be taken for prolonged periods.

Warnings
Do not use in case of individual hypersensitivity to one of the product components.
Safety of use during pregnancy and nursing has not been demonstrated. In such circumstances it is recommended to consult your physician.
There are no known interactions with other products, so it is advisable to consult your physician before using Refalgin tablets in association with other medical devices or medications.
Keep out of reach and sight of children.

Conservation
Store the product well closed in cool and dry place.

Format
Pack of 20 tablets of 1,3 g.

CE mark registration number
0373